Acumen Pharmaceuticals Exercises Option For Development, Production, Commercialization Of Two Candidates To Treat Alzheimer's Disease Through JCR Pharmaceuticals' Blood-Brain Barrier -Penetrating Technology Platform J-Brain Cargo
Acumen Pharmaceuticals Inc ABOS
$2.26
▲ +0.44%
(+$0.01)
Open
$2.32
Prev Close
$2.25
Day Range
$2.24 – $2.38
52W Range
$1.10 – $3.60
Market Cap
$163.23M
Beta
0.37
EPS (TTM)
$-1.86
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-01 |
| Shares Out. | 72,230,000 |
| Website | acumenpharm.com/ ↗ |
| Phone | 16173444190 |
Acumen Pharmaceuticals Inc is a publicly traded company under the ticker symbol ABOS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-06-01)